Every figure in an AXLRx brief — competitive, patient, and payer — is verified against a live source as it is written. If it can't be sourced, it doesn't ship. Delivered in 72 hours.
| Agent | mOS | Share |
|---|---|---|
| Pembrolizumab | 26.3 | 52% |
| Nivo + Ipi | 15.6 | 18% |
| Your asset | — | Ex.7 |
Every brand decision sits in one of four stages — each answering a single buyer question, each scoped to your asset. The brief types live inside them.
"What does the competitive and scientific landscape look like?"
"How large is the patient pool, and how reachable is it?"
"How do we size, deploy, and incentivise the team?"
"How is performance tracking, and where do we optimise?"
Not prose about the market — built exhibits a commercial team can decide on. Three from a typical brief, every figure sourced.
| Agent | PD-L1 | mOS | Share |
|---|---|---|---|
| Pembrolizumab | ≥50% | 26.3 | 52% |
| Nivo + Ipi | Any | 15.6 | 18% |
| Durvalumab | Any | 47.5 | 12% |
| Your asset | TBD | — | Ex.7 |
Commercial intelligence is where AI confidently reproduces outdated trials and figures that were never real. AXLRx uses none of its own memory as a source.
No confidence tiers. No "approximately." A figure that cannot clear the gate is removed.
Drug, mechanism, indication, target cohort, geography — five minutes. There is no generic template; the brief is built around what you submit.
We confirm scope, clarify the open questions, and lock the delivery window. One short call or email exchange settles it.
A decision-structured PDF, an editable Excel model, and an optional executive deck — with a 30-minute readout call.
MoatRx is a pharma and life-sciences strategy and analytics consultancy. When a decision needs more than a scoped brief — a full launch strategy, a market access dossier, or sales-force design — the same team takes it on directly.
AXLRx packages that consulting rigour into fixed-scope, fast-turnaround intelligence, on the same methodology and source discipline.
We build from your asset's clinical profile — mechanism, biomarker strategy, proposed label, and target cohort. Scope confirmation takes one call.
Start your request →or read a full sample brief before committing